Advertisement

Join Our Corporate Council

About the Corporate Council

The ACAAI Corporate Council offers companies exposure to nearly 6,000 allergists and immunologists, including more than 3,000 who are board-certified by the ABAI.  Participation in the Corporate Council also provides valuable access to the ACAAI Board of Regents and other key opinion leaders.

The Corporate Council is comprised of senior executives from pharmaceutical, medical device and other companies involved in the field of allergy and immunology. Two representatives from each participating company will hold seats on the Corporate Council and will be invited to the annual Corporate Council roundtable meeting.

The Council’s goal is to address critical issues in allergy and immunology, find solutions to pressing challenges, share knowledge of best practices and advise members on upcoming initiatives. By pooling resources and expertise, Corporate Council members and the ACAAI leadership can engage in joint problem-solving and explore collaborative opportunities to improve patient care and advance the mission of ACAAI.

To learn more about becoming a member of the ACAAI Corporate Council, please contact:

Linda Cullison
Director of Corporate Relations
American College of Allergy, Asthma & Immunology
Phone: 847-725-2291
Email: lindacullison@acaai.org

 

Partners

Abbvie

Abbvie
1 Waukegan Rd
North Chicago, IL 60064
www.abbvie.com

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Aimmune Therapeutics​
8000 Marina Blvd. Suite 300
Brisbane, CA 94005
www.aimmune.com

Aimmune Therapeutics, Inc. is a biopharmaceutical company developing and commercializing treatments for patients with food allergies. Aimmune was formed by leading food allergy stakeholders who concluded that a standardized oral immunotherapy approach was needed and that associated therapies needed to be developed. To deliver on that purpose, Aimmune developed the Characterized Oral Desensitization ImmunoTherapy (CODIT®) approach, which is intended to mitigate allergic reactions from accidental exposure to food allergens. Aimmune is the first company to have an FDA-approved treatment for any food allergy and is applying the CODIT approach to investigate additional food allergy therapies. Please visit www.aimmune.com .

Amgen​
One Amgen Center Drive
Thousand Oaks, CA 91320
www.amgen.com

At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.

AstraZeneca​
1800 Concord Pike
Wilmington, DE 19850
Tel: 800-236-9933
Tel: 877-810-6060
www.astrazeneca-us.com

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit www.astrazeneca-us.com.

Covis Pharma US
100 IMS Drive Parsippany
Parsippany, NJ 07054
covispharma.com

DBV Technologies
25 DeForest Avenue, Suite 203
Summit, NJ 07901
www.dbv-technologies.com

DBV Technologies is a global biopharmaceutical company that’s developing investigational epicutaneous immunotherapy (EPIT) technology to treat millions of people suffering from life-threatening food allergies and other immunological disorders. Starting with peanut, we are investigating food allergy treatments that are designed to potentially reduce the risk of unpredictable, life-threatening reactions due to accidental exposure.

Eli Lilly and Company
450 Kendall Street
Cambridge, MA 02142
www.lilly.com/

Genentech
1 DNA Way
South San Francisco, CA 94080
www.gene.com

Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California.

GSK
Five Moore Drive
Research Triangle Park, NC 27709
us.gsk.com/en-us/home/

GSK is a science-led global healthcare company with a special purpose: to help people. We research, develop and manufacture innovative pharmaceutical, biological, vaccine, and consumer healthcare products in an effort to bring differentiated, high-quality products, resources, and the science behind it all.

Incyte Corporation
1801 Augustine Cut-Off
Wilmington, DE 19803
www.incyte.com

Merck & Co., Inc.
351 North Sumneytown Pike
North Wales, PA 19454
www.merck.com

Novartis Pharmaceuticals Corporation
One Health Plaza
www.novartis.com/us-en

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Follow us at https://www.novartis.com, also on Twitter, Facebook and LinkedIn

Optinose
1020 Stony Hill Road, Suite 300
Yardley, PA 19067
Tel: 267-364-3500
www.optinose.com

Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. Our mission is to improve the quality of life for patients. We will accomplish that by becoming the leading specialty pharmaceutical company dedicated to creating innovative products that become standard of care for diseases cared for directly by, or in consultation with, ENT and allergy specialists.

Pfizer, Inc.
235 East 42nd Street
New York, NY 10017, USA
www.pfizer.com

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

Pharming Healthcare, Inc.
685 Route 202/206, Suite 202
Bridgewater, NJ 08807
Tel: 800-930-5221
www.pharming.com

Pharming Healthcare, Inc. is dedicated to providing life-changing solutions to patients. Pharming is currently involved in the development of drugs for the treatment of hereditary angioedema and has marketing operations in the United States, Israel, all 28 European Union countries plus Norway, Iceland, and Liechtenstein.

Sanofi US
55 Corporate Drive
Bridgewater, NJ 08807
www.sanofi.us/en

Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill Road
Tarrytown, NY 10591-6707
www.regeneron.com

Sanofi Genzyme and Regeneron are committed to providing resources to advance education and research in areas of unmet medical needs among patients with inflammatory and immunological diseases.

Stallergenes Greer

Stallergenes Greer
639 Nuway Circle
Lenoir, NC 28645
www.stallergenesgreerus.com

Headquartered in North Carolina, Stallergenes Greer’s business in the United States is part of a leading global biopharmaceutical company specializing in the development and commercialization of allergy immunotherapy (AIT) products and services for use in the diagnosis and treatment of allergies.

Takeda Pharmaceutical Company Limited
650 Kendall Street
Cambridge, MA 02142
www.takeda.com

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries. For more information, visit www.takeda.com.

Teva Pharmaceuticals
400 Interpace Parkway, #3
Parsippany, NJ 07054
www.tevausa.com/

Teva Pharmaceuticals has been developing and producing medicines for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

Advertisement